Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9949620 | 0.75 | TRPA1 (0.34) | — | |
| SCHEMBL13480281 | 0.74 | SHBG (0.36) | SHBG | |
| SCHEMBL4840529 | 0.74 | CA1 (0.41) | SHBG | |
| SCHEMBL25692572 | 0.74 | CA1 (0.41) | SHBG | |
| SCHEMBL9950163 | 0.74 | CA1 (0.39) | SHBG | |
| SCHEMBL18595189 | 0.74 | CA1 (0.41) | SHBG | |
| SCHEMBL24742714 | 0.73 | THRB (0.39) | SHBG | |
| SCHEMBL9154707 | 0.73 | THRB (0.39) | SHBG | |
| SCHEMBL2451853 | 0.73 | THRB (0.39) | SHBG | |
| SCHEMBL7591838 | 0.73 | SHBG (0.34) | SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2479159-A1 | PREPARATION METHOD FOR COMPOUND PROVIDED WITH DOUBLE BOND | Sumitomo Chemical Co., Ltd (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120165587-A1 | Method for Producing a Compound with a Double Bond | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165587-A1 | Method for Producing a Compound with a Double Bond | ADH1C, ADH1A, ADH5 | SHBG 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.